Verition Fund Management
ACIU icon

Verition Fund Management’s AC Immune ACIU Stock Holding History

Verition Fund Management’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-82,000
Closed -$400K – 1063
2020
Q3 		$400K Buy
+82,000
New +$588K 0.01% 668

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Verition Fund Management's ACIU Position: Q4 2021 in Review

Verition Fund Management sold out of AC Immune (ACIU) in Q4 2021, closing a stake of 56,744 shares — an estimated $381K sold.

Verition Fund Management first reported a position in ACIU in Q4 2019 and held it in 6 quarters. The position peaked at $988K in Q4 2020. 44 funds tracked by Wall St. Rank hold ACIU as of Q4 2021.

  • Verition Fund Management reported no remaining AC Immune position as of Q4 2021 after selling out during the quarter.
  • Verition Fund Management sold 56,744 AC Immune shares in Q4 2021, an estimated $381K.
  • Verition Fund Management first reported a position in AC Immune in Q4 2019 and held it in 6 quarters.
  • Verition Fund Management's AC Immune position peaked at $988K in Q4 2020.
  • 44 funds tracked by Wall St. Rank held AC Immune as of Q4 2021.

Based on Verition Fund Management's 13F filing for Q4 2021, filed 14 Feb 2022.